Franklin Resources
TXG icon

Franklin Resources’s 10x Genomics TXG Stock Holding History

Franklin Resources’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7M Sell
279,205
-7,193
-3% -$189K ﹤0.01% 1245
2026
Q1 		$6.08M Buy
286,398
+36,382
+15% +$727K ﹤0.01% 1441
2025
Q4 		$4.08M Sell
250,016
-99,786
-29% -$1.51M ﹤0.01% 1497
2025
Q3 		$4.09M Sell
349,802
-32,958
-9% -$430K ﹤0.01% 1493
2025
Q2 		$4.43M Buy
382,760
+316,144
+475% +$2.88M ﹤0.01% 1408
2025
Q1 		$582K Buy
66,616
+3,263
+5% +$41.1K ﹤0.01% 2204
2024
Q4 		$910K Buy
63,353
+68
+0.1% +$1.07K ﹤0.01% 2030
2024
Q3 		$1.03M Sell
63,285
-59,019
-48% -$1.22M ﹤0.01% 1970
2024
Q2 		$2.38M Sell
122,304
-758,860
-86% -$19.9M ﹤0.01% 1638
2024
Q1 		$33.1M Buy
881,164
+353,587
+67% +$15.5M 0.01% 713
2023
Q4 		$29.5M Sell
527,577
-97,803
-16% -$4.26M 0.01% 655
2023
Q3 		$25.8M Buy
625,380
+120,755
+24% +$6.28M 0.01% 676
2023
Q2 		$28.2M Buy
504,625
+411
+0.1% +$22.2K 0.01% 687
2023
Q1 		$28.1M Buy
504,214
+11,676
+2% +$545K 0.01% 683
2022
Q4 		$17.9M Sell
492,538
-21,659
-4% -$708K 0.01% 802
2022
Q3 		$14.6M Sell
514,197
-288,583
-36% -$11M 0.01% 852
2022
Q2 		$36.3M Buy
802,780
+117,264
+17% +$6.08M 0.02% 638
2022
Q1 		$52.1M Sell
685,516
-453,820
-40% -$39.7M 0.02% 590
2021
Q4 		$170M Sell
1,139,336
-108,945
-9% -$16.7M 0.06% 334
2021
Q3 		$182M Buy
1,248,281
+3,485
+0.3% +$598K 0.07% 320
2021
Q2 		$244M Buy
1,244,796
+49,530
+4% +$8.96M 0.09% 251
2021
Q1 		$216M Buy
1,195,266
+56,567
+5% +$9.77M 0.09% 254
2020
Q4 		$161M Buy
1,138,699
+337,612
+42% +$49M 0.07% 305
2020
Q3 		$99.9M Buy
801,087
+335,338
+72% +$35.2M 0.05% 384
2020
Q2 		$44.1M Buy
465,749
+244,903
+111% +$19.1M 0.02% 559
2020
Q1 		$13.8M Buy
220,846
+133,149
+152% +$10.4M 0.01% 752
2019
Q4 		$6.69M Buy
87,697
+142
+0.2% +$8.54K ﹤0.01% 959
2019
Q3 		$4.41M Buy
+87,555
New +$4.85M ﹤0.01% 1025

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources's TXG Position: Q2 2026 in Review

Franklin Resources reduced its 10x Genomics (TXG) stake by 2.5% in Q2 2026, selling an estimated $189K and leaving 279,205 shares worth $10.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1245.

Franklin Resources first reported a position in TXG in Q3 2019 and has held it in 28 quarters since. The position peaked at $244M in Q2 2021. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Franklin Resources held 279,205 shares of 10x Genomics worth $10.7M as of Q2 2026.
  • Franklin Resources sold 7,193 10x Genomics shares in Q2 2026, an estimated $189K.
  • 10x Genomics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #1245 holding.
  • Franklin Resources first reported a position in 10x Genomics in Q3 2019 and has held it in 28 quarters since.
  • Franklin Resources's 10x Genomics position peaked at $244M in Q2 2021.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.